To explore the treatment of psoriasis with sleep disorder by cooling blood and calming nerves: a randomized controlled trial
- Conditions
- Psoriasis
- Registration Number
- ITMCTR2100005257
- Lead Sponsor
- Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Psoriasis vulgaris was diagnosed and met the criteria of syndrome differentiation;
2. Mild and moderate sleep disorders, i.e. those with Pittsburgh sleep quality index (PSQI) score of 7 ~ 16;
3. Aged 18 to 65 years, regardless of nationality, gender and nationality;
4. Unlimited gender;
5. Voluntarily sign informed consent.
1. Critically ill subjects, subjects with acute diseases and subjects with mental disorders;
2. Persons with infection, pregnancy, childbirth, trauma and other stress states;
3. Those who use other drugs at the same time during treatment and cannot strictly implement the treatment plan;
4. Subjects who are allergic or intolerant to the drugs used in this study;
5. Previous or current subjects have any systemic diseases or other active skin diseases that may affect the research results;
6. The subjects had systematically applied glucocorticoids, immunosuppressants and retinoic acid preparations in recent 1 month, and used photochemotherapy and other local treatments within 2 weeks;
7. Used a research drug or participated in any research project in the first 30 days.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pittsburgh sleep quality index score;Psoriasis area and severity index score;
- Secondary Outcome Measures
Name Time Method Hamilton Anxiety Scale score;Traditional Chinese Medicine syndrome score;Dermatology quality of life scale score;Pruritus score;